MP-2019

N/A

Report date: 2025/01/26 15:55:11
NME

Base Information

Drug NameMP-2019
Drug Alias NameRAL GTPase inhibitors (University of Colorado)RAL GTPase inhibitors (Machavert Pharmaceuticals)Ral GTPase modulators (University of Colorado)MP-2019
ClassificationSmall molecules > Lipid
Mechanisms of ActionGTPase inhibitors
TargetsGTPase
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesMachavert Pharmaceuticals LLC
Inactive CompaniesUniversity Of Colorado SystemUniversity Of Colorado
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A